Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
1011.0000 -0.60 (-0.06%)
NSE Jul 16, 2025 12:05 PM
Volume: 1.2M
 

logo
Natco Pharma Ltd.
01 Jun 2021
1011.00
-0.06%
Ashika Research
Natco Pharma Ltd. (NPL) is a midsized pharmaceutical company with a presence across the pharma value chain. It owns eight manufacturing facilities including six formulations facilities and two API facilities. The company also has a US retail business. Natco is a leading domestic player in the oncology space. NPL's product pipeline consists of drugs,...
Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
More from Natco Pharma Ltd.
All Rapid Results
Recommended